Cargando…

COVID-19 therapeutic options for patients with kidney disease

Detalles Bibliográficos
Autores principales:	Izzedine, Hassan, Jhaveri, Kenar D., Perazella, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271263/ https://www.ncbi.nlm.nih.gov/pubmed/32317113 http://dx.doi.org/10.1016/j.kint.2020.03.015

Ejemplares similares

Genes, COVID-19 and phenotype
por: Izzedine, Hassan, et al.
Publicado: (2021)

Anaplastic lymphoma kinase inhibitors and their effect on the kidney
por: Bonilla, Marco, et al.
Publicado: (2022)

Acute tubulointerstitial nephritis and COVID-19
por: Ng, Jia H, et al.
Publicado: (2021)

Anticancer Drug-Induced Acute Kidney Injury
por: Izzedine, Hassan, et al.
Publicado: (2017)

Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19
por: Ng, Jia H., et al.
Publicado: (2020)

Electrolyte abnormalities in patients hospitalized with COVID-19
por: Malieckal, Deepa A, et al.
Publicado: (2021)

Acute Kidney Injury in the Patient with Cancer
por: Meraz-Munoz, Alejandro, et al.
Publicado: (2021)

In Reply to ‘Contrast-Enhanced CT in Patients With Kidney Disease: Some Considerations in Response to the ACR/NKF Consensus’
por: Perazella, Mark A., et al.
Publicado: (2020)

Cardio–renal service, time for a change
por: Uppal, Nupur N, et al.
Publicado: (2021)

Does treating with anti–PD-1 to improve glomerular health come without a cost?
por: Jhaveri, Kenar D., et al.
Publicado: (2022)

Nirogacestat and Hypophosphatemia
por: Gudsoorkar, Prakash, et al.
Publicado: (2023)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Kidney dysfunction due to AA amyloidosis in a morbidly obese female
por: Izzedine, Hassan, et al.
Publicado: (2023)

Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
por: Delafosse, Marion, et al.
Publicado: (2020)

Erratum to: Local anesthetics for the Nephrologist
por: Uppal, Nupur N, et al.
Publicado: (2021)

Local anesthetics for the Nephrologist
por: Uppal, Nupur N, et al.
Publicado: (2021)

Anticancer Drug-Induced Capillary Leak Syndrome
por: Izzedine, Hassan, et al.
Publicado: (2022)

The authors reply
por: Wanchoo, Rimda, et al.
Publicado: (2020)

Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials
por: Sprangers, Ben, et al.
Publicado: (2022)

Colchicine as a possible therapeutic option in COVID-19 infection
por: Parra-Medina, Rafael, et al.
Publicado: (2020)

Clofazimine: A potential therapeutic option for severe COVID-19
por: Ateya, Areej Mohamed
Publicado: (2021)

Utility of semi-private messaging application (WhatsApp®) for Onconephrology education: a qualitative analysis of a ‘mastermind’ chat
por: Khashu, Simoni, et al.
Publicado: (2021)

Diagnostic options for coronavirus disease 2019 (COVID-19)
por: Xiao, Yuanyuan, et al.
Publicado: (2020)

The looming pandemic of COVID-19: What therapeutic options do we have now?
por: Afsar, Nasir Ali
Publicado: (2020)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
por: Ng, Jia H., et al.
Publicado: (2020)

Biopsy-Proven Renal-Limited Thrombotic Microangiopathy in a Heart Transplant Recipient
por: Bharati, Joyita, et al.
Publicado: (2023)

The Role of Radiotherapy Among the Therapeutic Options for Castleman’s Disease
por: Karaca, Feryal, et al.
Publicado: (2014)

Pathology of COVID-19-associated acute kidney injury
por: Sharma, Purva, et al.
Publicado: (2021)

Hemodynamic Monitoring Options in COVID-19
por: Rozental, Olga, et al.
Publicado: (2020)

Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors
por: Gupta, Shruti, et al.
Publicado: (2021)

Is Sildenafil a Therapeutic Option for Noncompaction?
por: Finsterer, Josef, et al.
Publicado: (2014)

Stem cells as an option for the treatment of COVID-19
por: Cuevas-González, Maria Veronica, et al.
Publicado: (2022)

Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19()
por: Sánchez Cadena, Abraham David, et al.
Publicado: (2021)

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
por: Izzedine, Hassan, et al.
Publicado: (2022)

Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Diversifying online rheumatology education options in the era of COVID-19
por: Ahmed, Sakir, et al.
Publicado: (2020)

Acute kidney injury in patients hospitalized with COVID-19
por: Hirsch, Jamie S., et al.
Publicado: (2020)

Ureteroscopy for stones in solitary kidney: Preferred not just a standard option
por: Jones, Patrick, et al.
Publicado: (2016)

Cesarean section in COVID-19 patient with mitral stenosis: Fast-track spinal anesthesia is an option
por: Kumari, Poonam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rjej6bkekk1lknmlmvg49r5dav